Gene editing and food-waste biology, outside London
Pencil Biosciences raised £3.5m and Potenix £1.4m, two of 89 companies that filed £133.6m of new shares from 16 to 18 Nov 2026.
Pencil Biosciences works on gene editing for medicine. The company describes its platform as fully synthetic and modular, and says the non-CRISPR system can edit DNA without causing a break or nick. It cites therapeutics and cell line engineering as uses, and names oncology and genetic diseases among them.
Dr Amanda Smith is the chief executive, and Dr Rajik Ibrahim is listed as the founder and advisor. In September 2025 the company appointed Jonathan Thon as chair of its board. Pencil's registered office is in the North West of England. It raised £3.5m in October, with shares allotted on 19 Oct 2026 and the filing reaching Companies House on 18 Nov 2026. It is the company's first priced round in our data.
The second company works with food waste and farm residues. Potenix calls itself a UK engineering-biology and climate-technology company. Anaerobic digestion plants break down organic waste without oxygen, and Potenix makes a product, CatalystIQ, that it says is a pretreatment layer for existing plants, without replacing the digester.
The company says CatalystIQ analyzes each incoming load, matches it to a treatment from its engineered-biology library, applies that biology upstream of the digester, and then uses the plant's performance to refine later choices. It lists food waste, fats, oils and greases, agricultural residues, industrial organics and energy crops as the feedstocks it is built for. The company says its treatment unit is craned onto a pad and takes half a day to put in place.
The company says the feedstocks these plants take in change from load to load, and its product is built to treat each load differently. It says it does not manufacture digesters. The benefits it names are more energy and more consistent performance, and it adds that actual results depend on the plant, the feedstock and the trial configuration.
In June 2025 the company said Zinc VC had backed it. In November 2025 it said that agreements with established anaerobic digestion asset owners were taking CatalystIQ from controlled validation into deployment at working plants. Its registered office is at Tramshed Tech in Cardiff, and it also lists an office in London. Potenix raised £1.4m in November, with shares allotted on 17 Nov 2026 and the filing reaching Companies House on 18 Nov 2026. Like Pencil's, it is the company's first priced round on our records.
Region in these weekly counts means the registered office, so both companies count as outside London. From Monday to Wednesday, 16 to 18 Nov 2026, 89 companies filed priced share issues worth £133.6m. Of those, 49 were the company's first priced round on our records. London registered offices accounted for 48 rounds and £83.6m of the cash. The other 41 companies, registered elsewhere, accounted for £50.0m.
Sources
Learn more at bradshawdata.com. Corrections are listed with their dates.